Liquid Chromatography−Mass Spectrometry-Based Parallel Metabolic Profiling of Human and Mouse Model Serum Reveals Putative Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver Disease
- 15 July 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 9 (9), 4501-4512
- https://doi.org/10.1021/pr1002593
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in most western countries. Current NAFLD diagnosis methods (e.g., liver biopsy analysis or imaging techniques) are poorly suited as tests for such a prevalent condition, from both a clinical and financial point of view. The present work aims to demonstrate the potential utility of serum metabolic profiling in defining phenotypic biomarkers that could be useful in NAFLD management. A parallel animal model/human NAFLD exploratory metabolomics approach was employed, using ultra performance liquid chromatography−mass spectrometry (UPLC−MS) to analyze 42 serum samples collected from nondiabetic, morbidly obese, biopsy-proven NAFLD patients, and 17 animals belonging to the glycine N-methyltransferase knockout (GNMT-KO) NAFLD mouse model. Multivariate statistical analysis of the data revealed a series of common biomarkers that were significantly altered in the NAFLD (GNMT-KO) subjects in comparison to their normal liver counterparts (WT). Many of the compounds observed could be associated with biochemical perturbations associated with liver dysfunction (e.g., reduced Creatine) and inflammation (e.g., eicosanoid signaling). This differential metabolic phenotyping approach may have a future role as a supplement for clinical decision making in NAFLD and in the adaption to more individualized treatment protocols.Keywords
This publication has 99 references indexed in Scilit:
- Nonalcoholic Steatohepatitis, Animal Models, and Biomarkers: What Is New?Published by Springer Science and Business Media LLC ,2009
- Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease, 2008
- The role of fatty acids in the development and progression of nonalcoholic fatty liver diseaseThe Journal of Nutritional Biochemistry, 2008
- Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in miceHepatology, 2007
- Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersHepatology, 2007
- A Glycine N-methyltransferase Knockout Mouse Model for Humans with Deficiency of this EnzymeTransgenic Research, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeHepatology, 2003
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999